PRQR Latest Press Releases, Proqr Therapeuti Corporate News

Releases

1.440

-2.04%

-0.030

All
Financials
Insiders

6-K | ProQR Therapeutics N.V.(0001612940)
10/25/2024 12:08
424B5 | ProQR Therapeutics N.V.(0001612940)
10/24/2024 02:13
424B5 | ProQR Therapeutics N.V.(0001612940)
10/23/2024 02:19
EFFECT | ProQR Therapeutics N.V.(0001612940)
10/11/2024 02:02
424B5 | ProQR Therapeutics N.V.(0001612940)
10/10/2024 12:19
F-3 | ProQR Therapeutics N.V.(0001612940)
09/30/2024 13:07
6-K | ProQR Therapeutics N.V.(0001612940)
08/08/2024 03:03
6-K | ProQR Therapeutics N.V.(0001612940)
05/22/2024 12:20
6-K | ProQR Therapeutics N.V.(0001612940)
05/09/2024 03:03
6-K | ProQR Therapeutics N.V.(0001612940)
05/08/2024 04:08
6-K | ProQR Therapeutics N.V.(0001612940)
04/23/2024 03:07
6-K | ProQR Therapeutics N.V.(0001612940)
04/19/2024 03:07
20-F | ProQR Therapeutics N.V.(0001612940)
03/13/2024 04:46
6-K | ProQR Therapeutics N.V.(0001612940)
03/13/2024 03:11
6-K | ProQR Therapeutics N.V.(0001612940)
02/15/2024 02:48
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
02/14/2024 01:09
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
02/09/2024 01:38
6-K | ProQR Therapeutics N.V.(0001612940)
01/19/2024 02:09
6-K | ProQR Therapeutics N.V.(0001612940)
01/05/2024 02:09
6-K | ProQR Therapeutics N.V.(0001612940)
12/08/2023 02:38
6-K | ProQR Therapeutics N.V.(0001612940)
11/07/2023 05:02
6-K | ProQR Therapeutics N.V.(0001612940)
09/27/2023 03:07
SC 13G | ProQR Therapeutics N.V.(0001612940)
09/14/2023 13:21
6-K | ProQR Therapeutics N.V.(0001612940)
08/03/2023 03:17
6-K | ProQR Therapeutics N.V.(0001612940)
08/01/2023 03:16
CORRESP | ProQR Therapeutics N.V.(0001612940)
05/22/2023 08:36
UPLOAD | ProQR Therapeutics N.V.(0001612940)
05/22/2023 08:36
6-K | ProQR Therapeutics N.V.(0001612940)
05/17/2023 12:06
6-K | ProQR Therapeutics N.V.(0001612940)
05/16/2023 03:17
EFFECT | ProQR Therapeutics N.V.(0001612940)
04/25/2023 02:07
424B5 | ProQR Therapeutics N.V.(0001612940)
04/24/2023 12:37
6-K | ProQR Therapeutics N.V.(0001612940)
04/18/2023 04:06
F-3 | ProQR Therapeutics N.V.(0001612940)
03/29/2023 12:56
RW | ProQR Therapeutics N.V.(0001612940)
03/29/2023 12:56
20-F | ProQR Therapeutics N.V.(0001612940)
03/29/2023 12:09
6-K | ProQR Therapeutics N.V.(0001612940)
03/29/2023 04:09
6-K | ProQR Therapeutics N.V.(0001612940)
03/10/2023 11:11
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
02/14/2023 05:14
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
02/09/2023 12:01
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
02/09/2023 07:33
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
02/09/2023 06:59
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
02/08/2023 01:03
SC 13G/A | ProQR Therapeutics N.V.(0001612940)
12/23/2022 11:40
6-K | ProQR Therapeutics N.V.(0001612940)
12/23/2022 02:12
6-K | ProQR Therapeutics N.V.(0001612940)
11/09/2022 02:07
6-K | ProQR Therapeutics N.V. (0001612940)
09/21/2022 12:16
6-K | ProQR Therapeutics N.V.(0001612940)
08/11/2022 03:37
6-K | ProQR Therapeutics N.V.(0001612940)
08/04/2022 03:24
6-K | ProQR Therapeutics N.V.(0001612940)
06/30/2022 12:36
6-K | ProQR Therapeutics N.V.(0001612940)
06/01/2022 03:10

Webull provides the latest Proqr Therapeuti (PRQR) stock and general news. This information may help you make smarter investment decisions.

About PRQR

ProQR Therapeutics N.V. is a biotechnology company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. Main purpose of the Company is advancement of its Axiomer RNA-editing platform technology. That technology uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unaddressed needs. The Company operates research pipeline that contains of RNA Therapy and AX-0810 Cholestatic Diseases (NTCP).